Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus

J Autoimmun. 2022 Oct:132:102890. doi: 10.1016/j.jaut.2022.102890. Epub 2022 Aug 10.

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder characterized by a profound immune dysregulation and the presence of a variety of autoantibodies. Aberrant activation of programmed cell death (PCD) signaling and accelerated cell death is critical in the immunopathogenesis of SLE. Accumulating cellular components from the dead cells and ineffective clearance of the dead cell debris, in particular the nucleic acids and nucleic acids-protein complexes, provide a stable source of self-antigens, which potently activate auto-reactive B cells and promote IFN-I responses in SLE. Different cell types display distinct susceptibility and characteristics to a certain type of cell death, while different PCDs in various cells have mutual and intricate connections to promote immune dysregulation and contribute to the development of SLE. In this review, we discuss the role of various cell death pathways and their interactions in the pathogenesis of SLE. An in depth understanding of the interconnections among various forms cell death in SLE will lead to a better understanding of disease pathogenesis, shedding light on the development of novel therapeutic targets.

Keywords: Autoimmune response; Crosstalk; Immune dysregulation; Programmed cell death; Systemic lupus erythematosus.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Death
  • Cross Reactions
  • Humans
  • Lupus Erythematosus, Systemic*
  • Nucleic Acids*

Substances

  • Nucleic Acids